Overview

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

Summary

This is a phase 2 study to evaluate the safety and effectiveness of light-activated talaporfin sodium in patients with LUTS due to benign prostatic hyperplasia (BPH).

Phase:

Phase 2

Details

Lead Sponsor:

Light Sciences Oncology

Treatments:

Talaporfin